ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 165 filers reported holding ZOGENIX INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $965,000 | +7.0% | 59,400 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $902,000 | -52.8% | 59,400 | -46.3% | 0.02% | -59.7% |
| Q2 2021 | $1,911,000 | +582.5% | 110,583 | +671.8% | 0.06% | +520.0% |
| Q1 2021 | $280,000 | -67.3% | 14,328 | -66.6% | 0.01% | -68.8% |
| Q4 2020 | $857,000 | +66.4% | 42,856 | +49.2% | 0.03% | +3.2% |
| Q3 2020 | $515,000 | -65.6% | 28,716 | -48.2% | 0.03% | -69.6% |
| Q2 2020 | $1,498,000 | +580.9% | 55,471 | +1286.8% | 0.10% | +385.7% |
| Q1 2019 | $220,000 | -26.9% | 4,000 | -46.8% | 0.02% | -41.7% |
| Q1 2018 | $301,000 | -8.0% | 7,514 | -7.8% | 0.04% | -25.0% |
| Q4 2017 | $327,000 | -62.0% | 8,154 | -66.8% | 0.05% | -66.4% |
| Q3 2017 | $861,000 | +10.0% | 24,578 | -54.5% | 0.14% | -12.3% |
| Q2 2017 | $783,000 | +234.6% | 54,009 | +150.0% | 0.16% | +270.5% |
| Q1 2017 | $234,000 | -16.4% | 21,600 | +13.8% | 0.04% | -64.5% |
| Q4 2015 | $280,000 | +18.6% | 18,976 | +8.6% | 0.12% | +10.7% |
| Q3 2015 | $236,000 | – | 17,478 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,502,259 | $40,662,000 | 13.40% |
| HealthInvest Partners AB | 195,000 | $3,169,000 | 4.47% |
| CADIAN CAPITAL MANAGEMENT, LP | 4,090,846 | $66,476,000 | 3.66% |
| Prosight Management, LP | 362,909 | $5,897,000 | 3.53% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,284,705 | $20,876,000 | 1.97% |
| Kynam Capital Management, LP | 205,800 | $3,344,000 | 1.79% |
| Western Standard LLC | 160,656 | $2,611,000 | 1.54% |
| Ikarian Capital, LLC | 590,400 | $9,594,000 | 1.43% |
| RA Capital Management | 3,333,700 | $54,173,000 | 0.96% |
| Knott David M Jr | 134,688 | $2,189,000 | 0.74% |